Thai PBS Thai PBS
Asia-Pacific gets new weapon in fight against drug-resistant TB

Asia-Pacific gets new weapon in fight against drug-resistant TB

23 Sept 02:23 Key points summarised by AI
  • A new, highly effective drug regimen, BPaL, is being rolled out in the Asia-Pacific to combat drug-resistant tuberculosis (DR-TB), marking a potential "new era" in treatment.
  • The Asia-Pacific region bears the brunt of global TB cases and deaths, with previous DR-TB treatments being lengthy, painful, and having a success rate of only 63% or lower.
  • BPaL offers a significantly improved approach, demonstrating over 90% cure rates in just six months, with fewer pills and reduced side effects compared to older, 18-month regimens.
  • This life-changing treatment addresses critical issues like patient compliance and severe side effects, but ongoing challenges in diagnosis, stigma, and the need for increased investment persist.
Read full article
Health 1/1
Skip > Skip >